Skip to end of metadata
Go to start of metadata

You are viewing an old version of this page. View the current version.

Compare with Current View Page History

« Previous Version 7 Next »

4Meeting Name:

ELR Open Call #131

Moderator:

Vanessa Holley

Date:

Thursday, February 22, 2024

Notes:

Ray Lewis

Duration:

55 Minutes

Attendees:

Zoom Link:

Meeting Zoom Link Meeting ID: 940 4241 0458, Dial: (312) 626-6799

Recording Link

https://youtu.be/uRHHvfZFUE0

Zoom Chat Notes:

Propose Topics

ELR Open Forum Proposed Topics

Past Meeting Recordings & Notes

ELR Open Forum Dashboard - Weekly Agenda

Agenda

Presenter/Facilitator

Topic

ONC

CDC

USCDI+ and USCDI v5 Discussion

Vanessa Holley, APHL

Questions/Updates

Notes:

Presenter/Facilitator

Topic

Discussion:

Action Items

ONC

CDC

USCDI+ and USCDI v5 Discussion

USCDI plus comments were due March 4.

USCDI Version 5 comments are due Monday April 15.

ONC (Al Taylor (Medical Informatics Officer) and Katie

Draft USCDI Version 5

What is USCDI?

Comprises a core set of data needed to support patient care and facilitate patient access using health IT. USCDI establishes a consistent baseline of data for other use cases. They expand over time via a predictable, transparent, and collaborative public access.

ONC Cures Act Final Rule established USCDI v1 in 2020.

ONDEC Submission System-Anyone can submit a new data idea to this system.

ONDEC Levelling Criteria (0,1, and 2) Readiness, Feasibility, and applicability of data. The 4th category is breath of applicability.

Prioritization criteria for new USCDI Data Elements-Public Health, Underserved communities, Healthcare disparities and inequities, Behavioral health, and Key additions over past USCDI versions.

New Data Elements in Draft USCDI v5-Clinical Notes(Emergency Department Note, Operative Note), Medication (Route), Immunizations (Lot Number), Laboratory (Test kit Unique Device Identifier), New Data Class (Observations (Advance directive observation and Sex Parameter for clinical use)), New Data Class Orders, Provenance (Author and Author Role), and Patient Demographics Information (pronoun, Name to use, and Interpreter needed).

Drat USCDI v5 Update Cycle

Draft USCDI v5 Feedback Period

CDC

Other Discussion/Updates

Vanessa Holley, APHL

  • No labels